326 top medical experts on Respirovirus Infections across 36 countries and 24 U.S. states, including 166 MDs (Physicians). This is based on an objective analysis of their Scientific Publications, Clinical Trials, Medicare, and NIH Grants.

  1. Respirovirus Infections: Infections with viruses of the genus respirovirus, family paramyxoviridae. Host cell infection occurs by adsorption, via hemagglutinin, to the cell surface.
  2. Clinical guidelines are the recommended starting point to understand initial steps and current protocols in any disease or procedure:
  3. Broader Categories (#Experts): Paramyxoviridae Infections (808).


  

        

                    


    These expert listings are for individual use without a fee. Biotechs, Pharmaceuticals, Recruiters, Consultants, Investors, Law firms, and other organizations may use this only for quick evaluations (no downloads, screen scraping or using the data) to identify the top medical experts for recruiting, advisory panels, boards, and consulting. Please contact us for licensing, customized queries, feedback and questions.

  1. Greninger, Alexander L   Clinical Pathology/Laboratory Medicine   Google Publications
    Department of Laboratory Medicine, University of Washington, Seattle, Washington, USA. Top Hospital
    Physician  Highly Cited  Highly Published  Case Reports 
    Disclosed payments in 2021 from 2 biomedical companies, totalling $143.7, including $143.7 from  Abbott Laboratories
    Subjects: Parainfluenza Virus 3, Human; Adaptation, Biological; Alveolar Epithelial Cells; Cross Infection; Disease Outbreaks
    Categories: Virology; Epidemiology; Isolation & Purification; Pathogenicity; Pathology; Physiology
    Authentic Modeling of Human Respiratory Virus Infection in Human Pluripotent Stem Cell-Derived Lung Organoids. (2019)
    Rapid Metagenomic Next-Generation Sequencing during an Investigation of Hospital-Acquired Human Parainfluenza Virus 3 Infections. (2017)

  2. Moscona, Anne   Pediatrics   Google Publications
    Department of Pediatrics, Columbia University Medical Center, New York, New York, USA .
    Physician  Highly Published 
    Subjects: Parainfluenza Virus 3, Human; Adaptation, Biological; Alveolar Epithelial Cells; Genetic Fitness; HN Protein
    Categories: Virology; Metabolism; Growth & Development; Pathogenicity; Pathology; Physiology
    Authentic Modeling of Human Respiratory Virus Infection in Human Pluripotent Stem Cell-Derived Lung Organoids. (2019)
    Interaction between the hemagglutinin-neuraminidase and fusion glycoproteins of human parainfluenza virus type III regulates viral growth in vivo. (2013)

  3. Holtzman, Michael J   Pulmonary Disease   Google Publications
    Division of Pulmonary and Critical Care Medicine, Department of Internal Medicine, Washington University School of Medicine, St. Louis, MO.
    Physician  Highly Cited  Highly Published 
    Disclosed payments in 2021 from 6 biomedical companies, totalling $9,849.03, including $5,400 from  AstraZeneca Pharmaceuticals LP
    Subjects: Sendai virus; Influenza A virus; Lung Diseases; Orthomyxoviridae Infections; Asthma
    Categories: Immunology; Physiology; Pathology; Genetics; Complications; Metabolism
    BMAL1 links the circadian clock to viral airway pathology and asthma phenotypes. (2018)
    TREM-2 promotes macrophage survival and lung disease after respiratory viral infection. (2015)

  4. Grayson, Mitchell H   Pediatric Allergy/Immunology   Google Publications
    Division of Allergy and Immunology, Nationwide Childrens Hospital and The Ohio State University College of Medicine, Columbus, OH; .hussain@nationwidechildrens.org. Top Hospital
    Physician  Highly Published 
    Disclosed payments in 2021 from 7 biomedical companies, totalling $17,245.95, including $7,365 from  Merck Sharp & Dohme Corporation
    Subjects: Chemokines, CC; Asthma; Hypersensitivity, Immediate; Neutrophils; Sendai virus
    Categories: Immunology; Pathology; Antagonists & Inhibitors; Drug Therapy; Chemistry; Metabolism
    Cysteinyl leukotriene receptor 1 expression identifies a subset of neutrophils during the antiviral response that contributes to postviral atopic airway disease. (2018)
    Structure-function analysis of CCL28 in the development of post-viral asthma. (2015)

  5. Byers, Derek E   Pulmonary Disease  Google Publications
    Division of Pulmonary and Critical Care Medicine, Department of Internal Medicine, Washington University School of Medicine, St. Louis, MO.
    Physician  Highly Published 
    Medicare MIPS (Merit-based Incentive Payment System) rating: 84/100
    Disclosed payments in 2021 from 6 biomedical companies, totalling $308,800, including $308,800 from  AstraZeneca Pharmaceuticals LP
    Subjects: Sendai virus; Lung Diseases; Age Factors; Aging; Alarmins
    Categories: Immunology; Physiology; Complications; Physiopathology
    TREM-2 promotes macrophage survival and lung disease after respiratory viral infection. (2015)
    Basal epithelial stem cells cross an alarmin checkpoint for postviral lung disease. (2021)

  6. Karron, Ruth A   Diagnostic Radiology  Google Publications
    Center for Immunization Research, Department of International Health, Johns Hopkins Bloomberg School of Public Health, Baltimore, MD, USA.
    Physician  Highly Published  Clinical Trial 
    Disclosed payments in 2021 from 2 biomedical companies, totalling $3,002.76, including $1,800 from  Moderna TX, Inc.
    Subjects: Parainfluenza Vaccines; Parainfluenza Virus 3, Human; Vaccination; Antibodies, Viral; Drug Design
    Categories: Immunology; Methods; Adverse Effects; Prevention & Control; Administration & Dosage; Blood
    Progress in the development of human parainfluenza virus vaccines. (2011)
    Safety and infectivity of two doses of live-attenuated recombinant cold-passaged human parainfluenza type 3 virus vaccine rHPIV3cp45 in HPIV3-seronegative young children. (2013)

  7. Moss, Ronald B   Diagnostic Radiology  Google Publications
    Ansun BioPharma, San Diego, California.
    Physician  Highly Published  Case Reports 
    Subjects: Recombinant Fusion Proteins; Antiviral Agents; Parainfluenza Virus 3, Human; Immunocompromised Host; Lung Transplantation
    Categories: Drug Therapy; Adverse Effects; Therapeutic Use; Administration & Dosage; Drug Effects; Isolation & Purification
    Successful Treatment of Parainfluenza Virus Respiratory Tract Infection With DAS181 in 4 Immunocompromised Children. (2015)
    DAS181 treatment of severe parainfluenza type 3 pneumonia in a lung transplant recipient. (2013)

  8. Waghmare, Alpana   Pediatric Infectious Diseases  Google Publications
    University of Washington, Seattle, WA; Seattle Childrens Hospital, Seattle, WA; and Fred Hutchinson Cancer Research Center, Seattle, WA. Top Hospital
    Physician  Case Reports 
    Subjects: Recombinant Fusion Proteins; Hematopoietic Stem Cell Transplantation; Immunocompromised Host; Parainfluenza Virus 2, Human; Parainfluenza Virus 3, Human
    Categories: Drug Therapy; Drug Effects; Therapeutic Use; Pharmacology; Physiology
    How I treat respiratory viral infections in the setting of intensive chemotherapy or hematopoietic cell transplantation. (2016)
    Successful Treatment of Parainfluenza Virus Respiratory Tract Infection With DAS181 in 4 Immunocompromised Children. (2015)

  9. Buelow, Becky J   Allergy & Immunology  Google Publications
    Medical College of Wisconsin, Milwaukee, Wisconsin, USA.
    Physician 
    Medicare MIPS (Merit-based Incentive Payment System) rating: 72/100
    Disclosed payments from biomedical company (AstraZeneca Pharmaceuticals LP) in 2021 for $57.52
    Subjects: Chemokines, CC; Asthma; CD4-Positive T-Lymphocytes; Epithelial Cells; Receptors, CCR10
    Categories: Pathology; Antagonists & Inhibitors; Drug Therapy; Chemistry; Immunology; Metabolism
    Structure-function analysis of CCL28 in the development of post-viral asthma. (2015)
    POL7085 or anti-CCL28 treatment inhibits development of post-paramyxoviral airway disease. (2017)

  10. Cheung, Dorothy S   Allergy & Immunology  Google Publications
    Division of Allergy and Immunology, Department of Pediatrics, Medical College of Wisconsin, Milwaukee, Wis.
    Physician 
    Subjects: Allergens; Hypersensitivity, Immediate; Integrin alpha4; Nasal Mucosa; Neutrophils
    Categories: Immunology
    Cysteinyl leukotriene receptor 1 expression identifies a subset of neutrophils during the antiviral response that contributes to postviral atopic airway disease. (2018)
    Development of atopy by severe paramyxoviral infection in a mouse model. (2010)

  11. Bollard, Catherine M   Pediatric Hematology-Oncology  Google Publications
    Center for Cancer and Immunology Research, Childrens National Hospital, Washington, DC, United States.
    Physician 
    Disclosed payments in 2021 from 2 biomedical companies, totalling $1,899.86, including $1,899.86 from  SWEDISH ORPHAN BIOVITRUM AB
    Subjects: Parainfluenza Virus 3, Human; Adoptive Transfer; Antigens, Viral; CD4-Positive T-Lymphocytes; CD8-Positive T-Lymphocytes
    Categories: Immunology; Therapy; Methods; Transplantation
    Human parainfluenza virus-3 can be targeted by rapidly ex vivo expanded T lymphocytes. (2016)
    T-Cell Therapeutics Targeting Human Parainfluenza Virus 3 Are Broadly Epitope Specific and Are Cross Reactive With Human Parainfluenza Virus 1. (2020)

  12. Hayden, Randall T   Medical Microbiology  Google Publications
    Department of Pathology, St. Jude Childrens Research Hospital, Memphis, Tennessee, USA.
    Physician  Clinical Trial 
    Disclosed payments in 2021 from 2 biomedical companies, totalling $8,900, including $6,000 from  Quidel Corporation
    Subjects: Vaccines, Live, Unattenuated; Antibodies, Viral; Antiviral Agents; Parainfluenza Virus 1, Human; Parainfluenza Virus 2, Human
    Categories: Immunology; Administration & Dosage; Drug Effects; Pharmacology; Blood; Drug Therapy
    Safety and immunogenicity of an intranasal Sendai virus-based human parainfluenza virus type 1 vaccine in 3- to 6-year-old children. (2015)
    Inhibition of primary clinical isolates of human parainfluenza virus by DAS181 in cell culture and in a cotton rat model. (2013)

  13. Srinivasan, Ashok   Pediatric Hematology-Oncology   Google Publications
    Department of Bone Marrow Transplantation and Cellular Therapy, St. Jude Childrens Research Hospital, Memphis, Tennessee, USA charles.russell@stjude.org.
    Physician 
    Subjects: Sendai virus; Cyclophosphamide; Dexamethasone; Hematopoietic Stem Cell Transplantation; Immunotherapy
    Categories: Adverse Effects; Physiology; Therapeutic Use; Etiology; Immunology; Pathology
    Non-invasive Imaging of Sendai Virus Infection in Pharmacologically Immunocompromised Mice: NK and T Cells, but not Neutrophils, Promote Viral Clearance after Therapy with Cyclophosphamide and Dexamethasone. (2016)
    Dynamics of Sendai Virus Spread, Clearance, and Immunotherapeutic Efficacy after Hematopoietic Cell Transplant Imaged Noninvasively in Mice. (2018)

  14. Cunha, Burke A   Infectious Disease  Google Publications
    Infectious Disease Division,Infection Control Department,Winthrop-University Hospital,Mineola,New York;State University of New York School of Medicine,Stony Brook,New York.
    Physician  Case Reports 
    Subjects: Community-Acquired Infections; Hoarseness; Infection Control; Length of Stay; Monocytes
    Categories: Diagnosis; Epidemiology; Isolation & Purification; Pathology; Standards; Statistics & Numerical Data
    Infection Control Implications of Protracted Lengths of Stay With Noninfluenza Viral Influenza-Like Illnesses in Hospitalized Adults During the 2015 Influenza A (H3N2) Epidemic. (2015)
    Human parainfluenza virus type 3 (HPIV 3) community-acquired pneumonia (CAP) mimicking pertussis in an adult: the diagnostic importance of hoarseness and monocytosis. (2011)

  15. Russell, Charles J   General Practice   Google Publications
    Department of Infectious Diseases, St. Jude Childrens Research Hospital, Memphis, Tennessee, USA charles.russell@stjude.org.
    Physician  Highly Published  Clinical Trial 
    Subjects: Sendai virus; Viral Vaccines; Respiratory Tract Infections; Vaccines, Live, Unattenuated; Antibodies, Viral
    Categories: Immunology; Prevention & Control; Physiology; Virology; Administration & Dosage; Adverse Effects
    Safety and immunogenicity of an intranasal Sendai virus-based human parainfluenza virus type 1 vaccine in 3- to 6-year-old children. (2015)
    Illumination of parainfluenza virus infection and transmission in living animals reveals a tissue-specific dichotomy. (2011)

  16. Jones, Bart G   Ophthalmology   Google Publications
    Department of Infectious Diseases, St. Jude Childrens Research Hospital, Memphis, TN 38105, USA.
    Physician  Highly Published  Clinical Trial 
    Medical school: Other (MD, 1997)
    Medicare Accepted; Medicare MIPS (Merit-based Incentive Payment System) rating: 71.8/100
    Disclosed payments in 2021 from 13 biomedical companies, totalling $470.29, including $205.64 from  Mallinckrodt Hospital Products Inc.
    Subjects: Sendai virus; Parainfluenza Virus 1, Human; Vaccines, Live, Unattenuated; Antibodies, Viral; Antibody-Producing Cells
    Categories: Immunology; Administration & Dosage; Drug Effects; Pharmacology; Physiology; Prevention & Control
    Safety and immunogenicity of an intranasal Sendai virus-based human parainfluenza virus type 1 vaccine in 3- to 6-year-old children. (2015)
    Illumination of parainfluenza virus infection and transmission in living animals reveals a tissue-specific dichotomy. (2011)

  17. Jain, Deepika   Internal Medicine  Google Publications
    Department of Pathobiology, School of Veterinary Medicine, University of Pennsylvania, Philadelphia, Pennsylvania, United States of America. Top Hospital
    Physician  Highly Published 
    Disclosed payments in 2021 from 4 biomedical companies, totalling $58.74, including $15 from  AstraZeneca Pharmaceuticals LP
    Subjects: Sendai virus; CD4-Positive T-Lymphocytes; DEAD-box RNA Helicases; Granulocyte Colony-Stimulating Factor; Influenza A virus
    Categories: Immunology; Enzymology; Deficiency
    IL-27 Limits Type 2 Immunopathology Following Parainfluenza Virus Infection. (2017)
    Granulocyte colony-stimulating factor protects mice during respiratory virus infections. (2012)

  19. Keller, Michael D   Allergy & Immunology   Google Publications
    Center for Cancer and Immunology Research, Childrens National Hospital, Washington, DC, United States.
    Physician 
    Subjects: Parainfluenza Virus 3, Human; Adoptive Transfer; Antigens, Viral; CD4-Positive T-Lymphocytes; CD8-Positive T-Lymphocytes
    Categories: Immunology; Therapy; Methods; Transplantation
    Human parainfluenza virus-3 can be targeted by rapidly ex vivo expanded T lymphocytes. (2016)
    T-Cell Therapeutics Targeting Human Parainfluenza Virus 3 Are Broadly Epitope Specific and Are Cross Reactive With Human Parainfluenza Virus 1. (2020)

  20. Kwong, Peter D   Urology   Google Publications
    Vaccine Research Center, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, Washington, USA.
    Physician 
    Medical school: Virginia Commonwealth University, School of Medicine (MD, 1996)
    Medicare Accepted; Medicare MIPS (Merit-based Incentive Payment System) rating: 71/100
    Subjects: Parainfluenza Virus 3, Human; Viral Fusion Proteins; Antibodies, Monoclonal; Antibodies, Neutralizing; Antiviral Agents
    Categories: Immunology; Pharmacology; Chemistry; Antagonists & Inhibitors; Drug Effects; Prevention & Control
    Structure-based design of a quadrivalent fusion glycoprotein vaccine for human parainfluenza virus types 1-4. (2018)
    Protective antibodies against human parainfluenza virus type 3 infection. (2021)

Note:
  1. These experts have limited publications on this topic in our database, so expertise assessment may not be accurate.
  2. Only the top 20 experts are shown. You may filter your results or use the geolocation tabs. Contact us to purchase the entire list.
These expert listings are for individual use without a fee. Biotechs, Pharmaceuticals, Recruiters, Consultants, Investors, Law firms, and other organizations may use this only for quick evaluations (no downloads or screen scraping) to identify the top medical experts for recruiting, advisory panels, boards, and consulting. Please contact us for licensing, customized queries, feedback and questions.

);